These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 685891

  • 21. Bone changes during prednisone treatment.
    Deding A, Tougaard L, Krogh Jensen M, Rodbro P.
    Acta Med Scand; 1977; 202(4):253-5. PubMed ID: 562590
    [Abstract] [Full Text] [Related]

  • 22. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.
    Hahn TJ, Halstead LR, Strates B, Imbimbo B, Baran DT.
    Calcif Tissue Int; 1980; 31(2):109-15. PubMed ID: 6770974
    [No Abstract] [Full Text] [Related]

  • 23. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [Abstract] [Full Text] [Related]

  • 24. Bone mineral content in myelomatosis.
    Ingeberg S, Deding A, Jensen MK.
    Acta Med Scand; 1982; 211(1-2):19-21. PubMed ID: 7072520
    [Abstract] [Full Text] [Related]

  • 25. Long term follow-up of bone mineral status in children with renal disease.
    Chesney RW, Rose P, Mazess RB, DeLuca HF.
    Pediatr Nephrol; 1988 Jan; 2(1):22-6. PubMed ID: 3152995
    [Abstract] [Full Text] [Related]

  • 26. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J, Allen R, Hesp R, David J, Reid DM, Wright DJ, Green JR, Reeve J, Ansell BM, Woo PM.
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [Abstract] [Full Text] [Related]

  • 27. Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy.
    McAdams AJ, McEnery PT, West CD.
    J Pediatr; 1975 Jan; 86(1):23-31. PubMed ID: 1089142
    [Abstract] [Full Text] [Related]

  • 28. Delayed pubertal growth spurt in glomerulopathic boys receiving alternate-day prednisone.
    Polito C, Di Toro R.
    Child Nephrol Urol; 1992 Jan; 12(4):202-7. PubMed ID: 1473093
    [Abstract] [Full Text] [Related]

  • 29. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 30. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC, Kodroff MB, Landwehr DM.
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [Abstract] [Full Text] [Related]

  • 31. Normal growth of nephrotic children during long-term alternate-day prednisone therapy.
    Polito C, Oporto MR, Totino SF, La Manna A, Di Toro R.
    Acta Paediatr Scand; 1986 Mar; 75(2):245-50. PubMed ID: 3962658
    [Abstract] [Full Text] [Related]

  • 32. Juvenile periodontitis: skeletal bone mineral content.
    Von Wowern N, Stoltze K.
    J Clin Periodontol; 1977 Nov; 4(4):272-7. PubMed ID: 271654
    [Abstract] [Full Text] [Related]

  • 33. Calcium homeostasis and mineralization in puberty.
    Krabbe S.
    Dan Med Bull; 1989 Apr; 36(2):113-24. PubMed ID: 2651027
    [Abstract] [Full Text] [Related]

  • 34. Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate.
    Elzouki AY, Jaiswal OP.
    Clin Pediatr (Phila); 1988 Aug; 27(8):387-92. PubMed ID: 3135974
    [Abstract] [Full Text] [Related]

  • 35. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition.
    Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB.
    J Bone Miner Res; 2004 Dec; 19(12):1961-8. PubMed ID: 15537438
    [Abstract] [Full Text] [Related]

  • 36. Growth and development of children with renal transplants. Use of alternate-day steroid therapy.
    McEnery PT, Gonzalez LL, Martin LW, West CD.
    J Pediatr; 1973 Nov; 83(5):806-14. PubMed ID: 4582575
    [No Abstract] [Full Text] [Related]

  • 37. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
    Rooney M, Davies UM, Reeve J, Preece M, Ansell BM, Woo PM.
    J Rheumatol; 2000 Apr; 27(4):1073-81. PubMed ID: 10782840
    [Abstract] [Full Text] [Related]

  • 38. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 39. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA, Hanauer SB, Kirschner BS.
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
    [Abstract] [Full Text] [Related]

  • 40. Correlation of radial bone mineral content with total body calcium in chronic renal failure.
    Cohn SH, Ellis KJ, Caselnova RC, Asad SN, Letteri JM.
    J Lab Clin Med; 1975 Dec; 86(6):910-9. PubMed ID: 1194756
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.